Jump Financial, LLC Atea Pharmaceuticals, Inc. Transaction History

Jump Financial, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$4.35 - $6.17 $262,740 - $372,668	60,400 New	60,400 $290,000
Q4 2021 Feb 10, 2022	SELL	$7.67 - $44.59 $330,577 - $1.92 Million	-43,100 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$21.33 - $35.06 $663,363 - $1.09 Million	31,100 Added 259.17%	43,100 $1.51 Million
Q2 2021 Aug 13, 2021	BUY	$19.22 - $59.08 $160,852 - $494,440	8,369 Added 230.49%	12,000 $258,000
Q1 2021 May 17, 2021	BUY	$41.42 - $88.44 $150,396 - $321,125	3,631 New	3,631 $224,000

112

52.4M

900

126K

Ticker AVIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,258,600
Market Cap $271M
Description
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.